On Track: Monitoring Development of Children With Cerebral Palsy or Gross Motor Delay
Cerebral Palsy
Bottom Line
View on ClinicalTrials.gov: NCT02391948 ↗Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Pediatric · 0+ yrs
- Sex
- All
- Sponsor
- University of Washington
- Primary completion
- Aug 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Early Clinical Assessment of Balance (ECAB) |
79.4; 61.1; 38.0; 23.0; 7.3; 97.4 | — |
| PRIMARY Spinal Alignment and Range of Motion Measure (SAROMM) |
0.3; 0.6; 0.9; 1.1; 1.4; 0.4 | — |
| PRIMARY Functional Strength Assessment (FSA) |
4.0; 3.6; 3.1; 2.6; 1.8; 4.5 | — |
| PRIMARY Six and One-minute Walk Test (6MWT, 1MWT) |
1080.3; 697.3; 396.2; 1386.2; 1041.8; 616.9 | — |
| PRIMARY Early Activity Scale for Endurance (EASE) |
4.0; 3.6; 3.3; 2.7; 1.9; 3.7 | — |
| PRIMARY Child Health Conditions Questionnaire |
0.5; 0.9; 0.9; 1.4; 2.1; 0.7 | — |
| PRIMARY Child Engagement in Daily Life Measure (CEDL): Part 1 - Participation |
67.0; 65.1; 62.3; 55.8; 54.0; 70.2 | — |
| PRIMARY Child Engagement in Daily Life Measure (CEDL): Part 2 - Self-Care |
54.4; 49.0; 44.4; 33.6; 16.1; 73.0 | — |
| PRIMARY Services Questionnaire |
2.2; 2.5; 2.8; 2.9; 2.9; 2.2 | — |
| SECONDARY Percentage of All Participants According to Gross Motor Function Classification System (GMFCS) |
32.1; 22.7; 11.3; 18.2; 15.7 | — |
| SECONDARY Manual Ability Classification System (MACS) |
95; 33; 12; 4; 0; 121 | — |
| SECONDARY Communication Function Classification System (CFCS) |
144; 63; 34; 20; 3; 46 | — |
Summary
Eligibility Criteria
Inclusion Criteria
Families with a child who has a diagnosis of cerebral palsy or delayed motor development with muscle stiffness and difficulties with balance and moving.
Certain geographical areas of Canada and the US.
Exclusion Criteria
Children will be excluded if they have: 1) Diagnosis other than cerebral palsy (such as autism, Down syndrome, spinal cord injury, acute head injury, muscle disorder, developmental syndrome, genetic disorder); 2) Gross motor delay without associated problems with muscle tone, balance, and active movement; 3) are wards of the state; and 4) Families who do not speak English, French, or Spanish will not be eligible to participate in this study.
Data sourced from ClinicalTrials.gov (NCT02391948). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.